{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:22:42Z","timestamp":1792034562847,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["82100557"],"award-info":[{"award-number":["82100557"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Nantong","award":["JC2021018"],"award-info":[{"award-number":["JC2021018"]}]},{"name":"Large Instruments Open Foundation of Nantong University","award":["KFJN2279"],"award-info":[{"award-number":["KFJN2279"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mammalian LEM-domain proteins (LEMs) are encoded by seven genes, including LAP2, EMD, LEMD1, LEMD2, LEMD3, ANKLE1, and ANKLE2. Though some LEMs were involved in various tumor progression, the expression and prognostic values of LEMs in prostate adenocarcinoma (PRAD) have yet to be analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Herein, we investigated the expression, survival data, and immune infiltration levels of LEMs in PRAD patients from ATCG, TIMER, LinkedOmics, and TISIDB databases. We also further validated the mRNA and protein expression levels of ANKLE1, EMD, and LEMD2 in human prostate tumor specimens by qPCR, WB, and IHC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that all LEM expressions, except for that of LAP2, were markedly altered in PRAD compared to the normal samples. Among all LEMs, only the expressions of ANKLE1, EMD, and LEMD2 were correlated with advanced tumor stage and survival prognosis in PRAD. Consistent with the predicted computational results, the mRNA and protein expression levels of these genes were markedly increased in the PRAD group. We then found that ANKLE1, EMD, and LEMD2 expressions were markedly correlated with immune cell infiltration levels. High ANKLE1, EMD, and LEMD2 expressions predicted a worse prognosis in PRAD based on immune cells. DNA methylation or\/and copy number variations may contribute to the abnormal upregulation of ANKLE1, EMD, and LEMD2 in PRAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together, this study implied that ANKLE1, EMD, and LEMD2 were promising prognosis predictors and potential immunotherapy targets for PRAD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02640-z","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T01:06:01Z","timestamp":1654131961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-853X","authenticated-orcid":false,"given":"Tianzhen","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1242\/jcs.098392","volume":"125","author":"A Brachner","year":"2012","unstructured":"Brachner A, Braun J, Ghodgaonkar M, Castor D, Zlopasa L, Ehrlich V, et al. The endonuclease Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivo. J Cell Sci. 2012;125:1048\u201357.","journal-title":"J Cell Sci"},{"key":"2640_CR2","first-page":"329","volume":"56","author":"KK Lee","year":"2004","unstructured":"Lee KK, Wilson KL. All in the family: evidence for four new LEM-domain proteins Lem2 (NET-25), Lem3, Lem4 and Lem5 in the human genome. Symp Soc Exp Biol. 2004;56:329\u201339.","journal-title":"Symp Soc Exp Biol"},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2012.04.043","volume":"150","author":"C Asencio","year":"2012","unstructured":"Asencio C, Davidson IF, Santarella-Mellwig R, Ly-Hartig TB, Mall M, Wallenfang MR, et al. Coordination of kinase and phosphatase activities by Lem4 enables nuclear envelope reassembly during mitosis. Cell. 2012;150:122\u201335.","journal-title":"Cell"},{"key":"2640_CR4","first-page":"275","volume":"12","author":"D Yuki","year":"2004","unstructured":"Yuki D, Lin YM, Fujii Y, Nakamura Y, Furukawa Y. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep. 2004;12:275\u201380.","journal-title":"Oncol Rep"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1242\/jcs.02701","volume":"118","author":"A Brachner","year":"2005","unstructured":"Brachner A, Reipert S, Foisner R, Gotzmann J. LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins. J Cell Sci. 2005;118:5797\u2013810.","journal-title":"J Cell Sci"},{"key":"2640_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ceb.2003.11.012","volume":"16","author":"L Bengtsson","year":"2004","unstructured":"Bengtsson L, Wilson KL. Multiple and surprising new functions for emerin, a nuclear membrane protein. Curr Opin Cell Biol. 2004;16:73\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/bbrc.1997.7235","volume":"238","author":"K Furukawa","year":"1997","unstructured":"Furukawa K, Glass C, Kondo T. Characterization of the chromatin binding activity of lamina-associated polypeptide (LAP) 2. Biochem Biophys Res Commun. 1997;238:240\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2640_CR8","first-page":"3956","volume":"127","author":"JM Berk","year":"2014","unstructured":"Berk JM, Simon DN, Jenkins-Houk CR, Westerbeck JW, Gr\u00f8nning-Wang LM, Carlson CR, et al. The molecular basis of emerin-emerin and emerin-BAF interactions. J Cell Sci. 2014;127:3956\u201369.","journal-title":"J Cell Sci"},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1093\/emboj\/20.16.4399","volume":"20","author":"M Cai","year":"2001","unstructured":"Cai M, Huang Y, Ghirlando R, Wilson KL, Craigie R, Clore GM. Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J. 2001;20:4399\u2013407.","journal-title":"EMBO J"},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"13863","DOI":"10.1074\/jbc.M413020200","volume":"280","author":"M Mansharamani","year":"2005","unstructured":"Mansharamani M, Wilson KL. Direct binding of nuclear membrane protein MAN1 to emerin in vitro and two modes of binding to barrier-to-autointegration factor. J Biol Chem. 2005;280:13863\u201370.","journal-title":"J Biol Chem"},{"key":"2640_CR11","doi-asserted-by":"publisher","first-page":"e39482","DOI":"10.1371\/journal.pone.0039482","volume":"7","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Hwang SH, Han ME, Baek S, Sim HE, Yoon S, et al. LAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells. PLoS One. 2012;7:e39482.","journal-title":"PLoS One"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","volume":"118","author":"H Matsuyama","year":"2011","unstructured":"Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood. 2011;118:6881\u201392.","journal-title":"Blood"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.arcmed.2010.04.003","volume":"41","author":"S Ghafouri-Fard","year":"2010","unstructured":"Ghafouri-Fard S, Ousati Ashtiani Z, Sabah Golian B, Hasheminasab SM, Modarressi MH. Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer. Arch Med Res. 2010;41:195\u2013200.","journal-title":"Arch Med Res"},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40425-018-0398-7","volume":"6","author":"O Bakos","year":"2018","unstructured":"Bakos O, Lawson C, Rouleau S, Tai L-H. Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity. J ImmunoTher Cancer. 2018;6:86.","journal-title":"J ImmunoTher Cancer"},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2008;8:59\u201373.","journal-title":"Nat Rev Immunol"},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JTE, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15:409\u201325.","journal-title":"Nat Rev Cancer"},{"key":"2640_CR18","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.2741\/2441","volume":"12","author":"JB Aragon-Ching","year":"2007","unstructured":"Aragon-Ching JB, Williams KM, Gulley JL. Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer. Front Biosci. 2007;12:4957\u201371.","journal-title":"Front Biosci"},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12957-021-02325-z","volume":"19","author":"J He","year":"2021","unstructured":"He J, Yi M, Tan L, Huang J, Huang L. The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer. World J Surg Oncol. 2021;19:215.","journal-title":"World J Surg Oncol"},{"key":"2640_CR20","doi-asserted-by":"publisher","first-page":"T297","DOI":"10.1530\/ERC-17-0145","volume":"24","author":"M Gamat","year":"2017","unstructured":"Gamat M, McNeel DG. Androgen deprivation and immunotherapy for the treatment of prostate cancer. Endocr Relat Cancer. 2017;24:T297\u2013310.","journal-title":"Endocr Relat Cancer"},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","volume":"9","author":"MT Masucci","year":"2019","unstructured":"Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 2019;9:1146.","journal-title":"Front Oncol"},{"key":"2640_CR22","doi-asserted-by":"crossref","unstructured":"Bakshi D, Katoch A, Chakraborty S, Shah R, Sharma B, Bhat A, et al. ANKLE1 as new hotspot mutation for breast cancer in Indian population and has a role in DNA damage and repair in mammalian cells. Front Genet. 2021;11:609758.","DOI":"10.3389\/fgene.2020.609758"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1002\/ijc.32677","volume":"146","author":"J Tian","year":"2020","unstructured":"Tian J, Ying P, Ke J, Zhu Y, Yang Y, Gong Y, et al. ANKLE1 N(6)-methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability. Int J Cancer. 2020;146:3281\u201393.","journal-title":"Int J Cancer"},{"key":"2640_CR24","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1158\/0008-5472.CAN-18-0608","volume":"78","author":"M Reis-Sobreiro","year":"2018","unstructured":"Reis-Sobreiro M, Chen J-F, Novitskaya T, You S, Morley S, Steadman K, et al. Emerin deregulation links nuclear shape instability to metastatic potential. Cancer Res. 2018;78:6086.","journal-title":"Cancer Res"},{"key":"2640_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400\u2013416.e411.","journal-title":"Cell"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782\u201395.","journal-title":"Immunity"},{"key":"2640_CR29","first-page":"4435","volume":"25","author":"V K\u00e4rj\u00e4","year":"2005","unstructured":"K\u00e4rj\u00e4 V, Aaltomaa S, Lipponen P, Isotalo T, Talja M, Mokka R. Tumour-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. Anticancer Res. 2005;25:4435\u20138.","journal-title":"Anticancer Res"},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"517637","DOI":"10.3389\/fonc.2020.517637","volume":"10","author":"Z Wu","year":"2020","unstructured":"Wu Z, Chen H, Luo W, Zhang H, Li G, Zeng F, et al. The landscape of immune cells infiltrating in prostate cancer. Front Oncol. 2020;10:517637.","journal-title":"Front Oncol"},{"key":"2640_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12957-021-02449-2","volume":"19","author":"G Xu","year":"2021","unstructured":"Xu G, Meng Y, Wang L, Dong B, Peng F, Liu S, et al. miRNA-214-5p inhibits prostate cancer cell proliferation by targeting SOX4. World J Surg Oncol. 2021;19:338.","journal-title":"World J Surg Oncol"},{"key":"2640_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12957-021-02371-7","volume":"19","author":"Y Chen","year":"2021","unstructured":"Chen Y, Sun F, Zhang L, Zhou J, Hou J. miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2. World J Surg Oncol. 2021;19:250.","journal-title":"World J Surg Oncol"},{"key":"2640_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12957-021-02287-2","volume":"19","author":"L Qin","year":"2021","unstructured":"Qin L, Sun X, Zhou F, Liu C. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1. World J Surg Oncol. 2021;19:184.","journal-title":"World J Surg Oncol"},{"key":"2640_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12957-020-01850-7","volume":"18","author":"G Liao","year":"2020","unstructured":"Liao G, Tang J, Wang D, Zuo H, Zhang Q, Liu Y, et al. Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16. World J Surg Oncol. 2020;18:81.","journal-title":"World J Surg Oncol"},{"key":"2640_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1477-7819-12-284","volume":"12","author":"J Li","year":"2014","unstructured":"Li J, Wang Z, Chong T, Chen H, Li H, Li G, et al. Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion. World J Surg Oncol. 2014;12:284.","journal-title":"World J Surg Oncol"},{"key":"2640_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633\u201340.","journal-title":"Trends Immunol"},{"key":"2640_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503\u201310.","journal-title":"Nat Immunol"},{"key":"2640_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1593\/neo.121758","volume":"15","author":"A Bruno","year":"2013","unstructured":"Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, et al. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013;15:133\u201342.","journal-title":"Neoplasia"},{"key":"2640_CR39","doi-asserted-by":"publisher","first-page":"dju200","DOI":"10.1093\/jnci\/dju200","volume":"106","author":"A Bruno","year":"2014","unstructured":"Bruno A, Ferlazzo G, Albini A, Noonan DM. A think tank of TINK\/TANKs: tumor-infiltrating\/tumor-associated natural killer cells in tumor progression and angiogenesis. J Natl Cancer Inst. 2014;106:dju200.","journal-title":"J Natl Cancer Inst"},{"key":"2640_CR40","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1096\/fj.201701103R","volume":"32","author":"A Bruno","year":"2018","unstructured":"Bruno A, Bassani B, D\u2019Urso DG, Pitaku I, Cassinotti E, Pelosi G, et al. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. FASEB J. 2018;32:5365\u201377.","journal-title":"FASEB J"},{"key":"2640_CR41","doi-asserted-by":"publisher","first-page":"e9247","DOI":"10.15252\/msb.20199247","volume":"16","author":"M Oberhuber","year":"2020","unstructured":"Oberhuber M, Pecoraro M, Rusz M, Oberhuber G, Wieselberg M, Haslinger P, et al. STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. Mol Syst Biol. 2020;16:e9247.","journal-title":"Mol Syst Biol"},{"key":"2640_CR42","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1126\/science.1086887","volume":"301","author":"SI Grewal","year":"2003","unstructured":"Grewal SI, Moazed D. Heterochromatin and epigenetic control of gene expression. Science. 2003;301:798\u2013802.","journal-title":"Science"},{"key":"2640_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143\u201353.","journal-title":"Nat Rev Cancer"},{"key":"2640_CR44","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21:5400\u201313.","journal-title":"Oncogene"},{"key":"2640_CR45","doi-asserted-by":"publisher","first-page":"761909","DOI":"10.1100\/2012\/761909","volume":"2012","author":"P Hudler","year":"2012","unstructured":"Hudler P. Genetic aspects of gastric cancer instability. ScientificWorldJournal. 2012;2012:761909.","journal-title":"ScientificWorldJournal"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02640-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T02:04:05Z","timestamp":1654135445000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02640-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02640-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"18 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the datasets were retrieved from the published literature, so it was confirmed that all written informed consent was obtained. Reusable datasets for our analysis comply with relevant ethical regulations.The studies in which human prostate tumor samples were collected were approved by the ethical committees of the Affiliated Hospital of Qingdao University. Written consent was obtained from all patients and healthcare workers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}